Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Immunocore

Dow Jones Rallies Despite This Risk; These 3 Warren Buffett Stocks Eye Entries; Microsoft Pops

The Dow Jones rallied despite a looming risk. A trio of Warren Buffett stocks are near buy points. Microsoft stock, an AI play, popped.

Investors Business Daily

Biotech's Drug Pipeline Expands From Melanoma To Other Cancers

Immunocore is the IBD Stock of the Day as the biotech company expands its pipeline. Earnings For IMCR stock are due in March.

Investors Business Daily

Why IBD Stock Of The Day Immunocore Has Rocketed 233% Since January

Immunocore is the IBD Stock Of The Day as expectations for triple-digit sales growth and future profits drive the biotech stock higher.

Investors Business Daily

From analysis to the latest developments in health,
read the most diverse news in one place.

Important Biotech Catalysts For September 9, 2022 - End Of The Day Summary

The U.S. Food and Drug Administration (FDA) has approved Spectrum Pharmaceuticals’ (NASDAQ:SPPI) lead asset ROLVEDON (eflapegrastim-xnst) injection to decrease the incidence of infection, as manifested by febrile neutropenia. Spectrum Pharmaceuticals shares traded as high as 3.17 percent, in a range of $1.21 to $1.30 on day volume of 6.8 million…

Benzinga

15 Biotech Stocks That Hit Year Highs Over The Last Week, Including Sarepta, Axsome

In recent days, biotech stocks have slowed their early-August sprint. But not all shares are ready to hit the showers.

Investors Business Daily

Immunocore Eye Cancer Cell Therapy Scores European Approval

The European Commission (EC)

Benzinga

The Daily Biotech Pulse: Gilead's Blood Cancer Studies Placed On Partial Clinical Hold, Immunocore Gets FDA Nod, NRx Touts Positive COVID-19 Data

Here's a roundup of top developments in the biotech space over the last 24 hours.

Benzinga

Read news from The Economist, FT, and more,
with one subscription

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

US Food and Drug Administration

Read news from The Economist, FT, and more,
with one subscription

Topics

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.